Short answer
Amphastar Pharmaceuticals, Inc. (AMPH) filed an 8-K current report with the SEC on June 3, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All three Class I director nominees elected through the 2029 annual meeting.
Amphastar Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All three Class I director nominees elected through the 2029 annual meeting
- Ernst & Young LLP ratified as independent auditor for fiscal year ending December 31, 2026
- Executive compensation approved on an advisory basis, with 32,585,908 votes in favor
- Annual advisory votes on executive compensation selected, with 33,816,071 votes for one-year frequency
- Annual say-on-pay vote requirement extends through the 2032 annual meeting at latest
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Amphastar Pharmaceuticals, Inc. 8-K filings
Get the next AMPH 8-K as it lands
Follow AMPH for push alerts, or ask the research agent what this filing means.